Michael S. Weiss

Michael S. Weiss

Chief Executive Officer and PresidentatTG Therapeutics· In proxies 2021–2025

Pay in FY2025+36% from the year before · TG Therapeutics stock -1.0% the same year

Michael S. Weiss was paid $25.6M in FY2025 (Dec), up 36%. TG Therapeutics stock fell 1.0% that year.

Pay$100 in the stock at the end of FY20 → $57
Pay is from the Summary Compensation Table of each TG Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. TG TherapeuticsPublic company · 5 yr
    • Chief Executive Officer and President2021 – Present · 5 yrStock in role +8%
  2. Checkpoint Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Fortress Biotech, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Mustang Bio, IncPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?